143 related articles for article (PubMed ID: 36587749)
21. Downregulation of RIF1 Enhances Sensitivity to Platinum-Based Chemotherapy in Epithelial Ovarian Cancer (EOC) by Regulating Nucleotide Excision Repair (NER) Pathway.
Liu YB; Mei Y; Tian ZW; Long J; Luo CH; Zhou HH
Cell Physiol Biochem; 2018; 46(5):1971-1984. PubMed ID: 29719287
[TBL] [Abstract][Full Text] [Related]
22. Expression of SKA1 and MMP-9 in primary salivary adenoid cystic carcinoma: Correlation with tumor progression and patient prognosis.
Zhao L; Jiang L; Du P; Zhang D; Liu Z; Li K; Zhang B
Acta Otolaryngol; 2016 Jun; 136(6):575-9. PubMed ID: 26881872
[TBL] [Abstract][Full Text] [Related]
23. RCC2, a regulator of the RalA signaling pathway, is identified as a novel therapeutic target in cisplatin-resistant ovarian cancer.
Gong S; Chen Y; Meng F; Zhang Y; Wu H; Li C; Zhang G
FASEB J; 2019 Apr; 33(4):5350-5365. PubMed ID: 30768358
[TBL] [Abstract][Full Text] [Related]
24. MiR-30a-5p/CHD1 axis enhances cisplatin sensitivity of ovarian cancer cells via inactivating the Wnt/β-catenin pathway.
Wang X; Zhao H; Wang P; Zhang J; Li N; Liu Y; Zhang F; Yu Y
Anticancer Drugs; 2022 Nov; 33(10):989-998. PubMed ID: 36206129
[TBL] [Abstract][Full Text] [Related]
25. Nuclear orphan receptor NR2F6 confers cisplatin resistance in epithelial ovarian cancer cells by activating the Notch3 signaling pathway.
Li H; Zhang W; Niu C; Lin C; Wu X; Jian Y; Li Y; Ye L; Dai Y; Ouyang Y; Chen J; Qiu J; Song L; Zhang Y
Int J Cancer; 2019 Oct; 145(7):1921-1934. PubMed ID: 30895619
[TBL] [Abstract][Full Text] [Related]
26. Upregulation of ITGBL1 predicts poor prognosis and promotes chemoresistance in ovarian cancer.
Song J; Yang P; Lu J
Cancer Biomark; 2020; 27(1):51-61. PubMed ID: 31683459
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic silencing of SFRP5 is related to malignant phenotype and chemoresistance of ovarian cancer through Wnt signaling pathway.
Su HY; Lai HC; Lin YW; Liu CY; Chen CK; Chou YC; Lin SP; Lin WC; Lee HY; Yu MH
Int J Cancer; 2010 Aug; 127(3):555-67. PubMed ID: 19957335
[TBL] [Abstract][Full Text] [Related]
28. SKA1/2/3 is a biomarker of poor prognosis in human hepatocellular carcinoma.
Song GQ; He TL; Ji KJ; Duan YM; Zhang JW; Hu GQ
Front Oncol; 2022; 12():1038925. PubMed ID: 36439516
[TBL] [Abstract][Full Text] [Related]
29. Knockdown of SKA1 gene inhibits cell proliferation and metastasis in human adenoid cystic carcinoma.
Zhao LJ; Yang HL; Li KY; Gao YH; Dong K; Liu ZH; Wang LX; Zhang B
Biomed Pharmacother; 2017 Jun; 90():8-14. PubMed ID: 28340379
[TBL] [Abstract][Full Text] [Related]
30. PPARγ promotes diabetes-associated centrosome amplification via increasing the expression of SKA1 directly at the transcriptional level.
Liu QQ; Wang P; He QJ; Ma R; Lee SC
J Cell Physiol; 2019 Nov; 234(11):20694-20703. PubMed ID: 30989671
[TBL] [Abstract][Full Text] [Related]
31. SKA1/2/3 serves as a biomarker for poor prognosis in human lung adenocarcinoma.
Chen C; Guo Q; Song Y; Xu G; Liu L
Transl Lung Cancer Res; 2020 Apr; 9(2):218-231. PubMed ID: 32420061
[TBL] [Abstract][Full Text] [Related]
32. Lentivirus-mediated silencing of spindle and kinetochore-associated protein 1 inhibits the proliferation and invasion of neuronal glioblastoma cells.
Shi X; Chen X; Peng H; Song E; Zhang T; Zhang J; Li J; Swa H; Li Y; Kim S; Liu X; Zhang C
Mol Med Rep; 2015 May; 11(5):3533-8. PubMed ID: 25573192
[TBL] [Abstract][Full Text] [Related]
33. Knockdown of Eag1 Expression by RNA Interference Increases Chemosensitivity to Cisplatin in Ovarian Cancer Cells.
Hui C; Lan Z; Yue-li L; Li-lin H; Li-lin H
Reprod Sci; 2015 Dec; 22(12):1618-26. PubMed ID: 26079730
[TBL] [Abstract][Full Text] [Related]
34. UBE2S promotes the development of ovarian cancer by promoting PI3K/AKT/mTOR signaling pathway to regulate cell cycle and apoptosis.
Zhang M; Liu Y; Yin Y; Sun Z; Wang Y; Zhang Z; Li F; Chen X
Mol Med; 2022 Jun; 28(1):62. PubMed ID: 35658829
[TBL] [Abstract][Full Text] [Related]
35. SKA1 over-expression promotes centriole over-duplication, centrosome amplification and prostate tumourigenesis.
Li J; Xuan JW; Khatamianfar V; Valiyeva F; Moussa M; Sadek A; Yang BB; Dong BJ; Huang YR; Gao WQ
J Pathol; 2014 Oct; 234(2):178-89. PubMed ID: 24827423
[TBL] [Abstract][Full Text] [Related]
36. SKA1 induces de novo MTX-resistance in osteosarcoma through inhibiting FPGS transcription.
Yu W; Min D; Lin F; Zheng S; Tang L; He A; Hu H; Shen Z
FEBS J; 2019 Jun; 286(12):2399-2414. PubMed ID: 30851225
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression.
Deng J; Bai X; Feng X; Ni J; Beretov J; Graham P; Li Y
BMC Cancer; 2019 Jun; 19(1):618. PubMed ID: 31234823
[TBL] [Abstract][Full Text] [Related]
38. The effects of REG4 expression on chemoresistance of ovarian cancer.
Xiang LW; Xue H; Ha MW; Yu DY; Xiao LJ; Zheng HC
J Obstet Gynaecol; 2022 Oct; 42(7):3149-3157. PubMed ID: 35929918
[TBL] [Abstract][Full Text] [Related]
39. Microtubule Tip Tracking by the Spindle and Kinetochore Protein Ska1 Requires Diverse Tubulin-Interacting Surfaces.
Monda JK; Whitney IP; Tarasovetc EV; Wilson-Kubalek E; Milligan RA; Grishchuk EL; Cheeseman IM
Curr Biol; 2017 Dec; 27(23):3666-3675.e6. PubMed ID: 29153323
[TBL] [Abstract][Full Text] [Related]
40. TTK inhibition increases cisplatin sensitivity in high-grade serous ovarian carcinoma through the mTOR/autophagy pathway.
Qi G; Ma H; Li Y; Peng J; Chen J; Kong B
Cell Death Dis; 2021 Dec; 12(12):1135. PubMed ID: 34876569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
